3 workers burned at Callaway nuclear plant
FULTON, Mo. (AP) - Three employees have been injured in an accident at a nuclear plant in central Missouri.
Local emergency managers say workers were burned last night at the Callaway Energy Center about 25 miles northeast of Jefferson City.
Ameren says the accident didn't affect operations at the plant.
Latest News
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8

A BIT SLIMMER: CHRISTIE HAS WEIGHT-LOSS SURGERY
NEWARK, N.J. (AP) -- Gov. Chris Christie, who once famously called himself "the healthiest fat guy you've ever seen," disclosed Tuesday he had secretly undergone weight-loss surger...

Early number sense plays role in later math skills
By LAURAN NEERGAARD, AP Medical Writer WASHINGTON (AP) - We know a lot about how babies learn to talk, and youngsters learn to read. Now scientists are unraveling the earlies...

Study: Better TV might improve kids' behavior
SEATTLE (AP) - A new study has found teaching parents to switch channels from violent shows to educational TV can improve preschoolers' behavior, even without getting them to watch...

ANGER, FEAR, TEARS NORMAL RESPONSE TO DISASTERS
BOSTON (AP) -- Kaitlyn Greeley burst into tears when a car backfired the other day. She's afraid to take her usual train to her job at a Boston hospital, walking or taking cabs ins...

SURGERY, THERAPY BOTH PROVE GOOD FOR KNEE REPAIR
You might not want to rush into knee surgery. Physical therapy can be just as good for a common injury and at far less cost and risk, the most rigorous study to compare these treat...

US SUICIDE RATE ROSE SHARPLY AMONG MIDDLE-AGED
NEW YORK (AP) -- The suicide rate among middle-aged Americans climbed a startling 28 percent in a decade, a period that included the recession and the mortgage crisis, the governme...

TENNIS ELBOW? STEROID SHOTS NOT BEST LONG-TERM FIX
CHICAGO (AP) -- Commonly used steroid shots may worsen tennis elbow in the long run and increase chances that the painful condition will reappear, a small study found. By contra...

FDA APPROVES RETURN OF DRUG FOR MORNING SICKNESS
WASHINGTON (AP) -- Talk about a comeback: A treatment pulled off the market 30 years ago has won Food and Drug Administration approval again as the only drug specifically designate...